114 related articles for article (PubMed ID: 17094448)
21. Quantitative evaluation of the murine B16 melanoma tumor model after gene marking with an EGFP/Neo expressing retroviral vector.
Hansen BD; Duch M; Hokland P; Pedersen FS; Hokland M
In Vivo; 2002; 16(3):167-74. PubMed ID: 12182111
[TBL] [Abstract][Full Text] [Related]
22. Biodistribution and tumor localization of lymphokine-activated killer T cells following different routes of administration into tumor-bearing animals.
Kjaergaard J; Hokland ME; Agger R; Skovbo A; Nannmark U; Basse PH
Cancer Immunol Immunother; 2000 Jan; 48(10):550-60. PubMed ID: 10630307
[TBL] [Abstract][Full Text] [Related]
23. [Augmentation of LAK cell-accumulation in tumor tissue and its therapeutic effect after chemotherapy].
Wakizaka Y; Uchino J
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1441-4. PubMed ID: 1530290
[TBL] [Abstract][Full Text] [Related]
24. Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein.
Rüttinger D; Li R; Poehlein CH; Haley D; Walker EB; Hu HM; Fox BA
J Immunother; 2008 Jan; 31(1):43-51. PubMed ID: 18157011
[TBL] [Abstract][Full Text] [Related]
25. Endothelial cell-based systemic gene therapy of metastatic melanoma.
Ojeifo JO; Lee HR; Rezza P; Su N; Zwiebel JA
Cancer Gene Ther; 2001 Sep; 8(9):636-48. PubMed ID: 11593332
[TBL] [Abstract][Full Text] [Related]
26. Unbiased selection of bone marrow derived cells as carriers for cancer gene therapy.
Lang SI; Kottke T; Thompson J; Vile RG
J Gene Med; 2007 Nov; 9(11):927-37. PubMed ID: 17721895
[TBL] [Abstract][Full Text] [Related]
27. Genetically fluorescent melanoma bone and organ metastasis models.
Yang M; Jiang P; An Z; Baranov E; Li L; Hasegawa S; Al-Tuwaijri M; Chishima T; Shimada H; Moossa AR; Hoffman RM
Clin Cancer Res; 1999 Nov; 5(11):3549-59. PubMed ID: 10589771
[TBL] [Abstract][Full Text] [Related]
28. [Immunoprophylactic and immunotherapeutic effects of adoptively transferred LAK cells on L615 leukemia suffering mice].
Zhao TH
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):282-5. PubMed ID: 7513634
[TBL] [Abstract][Full Text] [Related]
29. [Study on adoptive immunotherapy for experimental brain tumor].
Takai N
No To Shinkei; 1988 Jul; 40(7):689-95. PubMed ID: 3265631
[TBL] [Abstract][Full Text] [Related]
30. Morphological studies of effector cell-microvessel interactions in adoptive immunotherapy in tumor-bearing animals.
Nannmark U; Basse P; Johansson BR; Kuppen P; Kjergaard J; Hokland M
Nat Immun; 1996-1997; 15(2-3):78-86. PubMed ID: 9162266
[TBL] [Abstract][Full Text] [Related]
31. Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanoma.
Kline J; Brown IE; Zha YY; Blank C; Strickler J; Wouters H; Zhang L; Gajewski TF
Clin Cancer Res; 2008 May; 14(10):3156-67. PubMed ID: 18483384
[TBL] [Abstract][Full Text] [Related]
32. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.
Bouvet M; Tsuji K; Yang M; Jiang P; Moossa AR; Hoffman RM
Cancer Res; 2006 Dec; 66(23):11293-7. PubMed ID: 17145875
[TBL] [Abstract][Full Text] [Related]
33. C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis.
van Deventer HW; O'Connor W; Brickey WJ; Aris RM; Ting JP; Serody JS
Cancer Res; 2005 Apr; 65(8):3374-9. PubMed ID: 15833871
[TBL] [Abstract][Full Text] [Related]
34. Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis.
Hu K; Xiong J; Ji K; Sun H; Wang J; Liu H
Immunol Lett; 2007 Oct; 113(1):19-28. PubMed ID: 17868906
[TBL] [Abstract][Full Text] [Related]
35. [Fluorescent imaging of angiogenesis and spontaneous metastasis in transplanted hepatoma: experiment with mice].
Wang Y; Feng GS; Tian H; Zhang ZH; Xiong T
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3307-9. PubMed ID: 18396632
[TBL] [Abstract][Full Text] [Related]
36. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
[TBL] [Abstract][Full Text] [Related]
37. Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model.
Alici E; Konstantinidis KV; Sutlu T; Aints A; Gahrton G; Ljunggren HG; Dilber MS
Exp Hematol; 2007 Dec; 35(12):1839-46. PubMed ID: 18036444
[TBL] [Abstract][Full Text] [Related]
38. [Transplantation of human glioma stem cells in nude mice with green fluorescent protein expression].
Wu ZC; Huang Q; Shao YX; Xue ZM; Dong J; Diao Y; Wang AD; Lan Q
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2317-20. PubMed ID: 19087690
[TBL] [Abstract][Full Text] [Related]
39. [Eukaryotic vectors of Celo avian adenovirus genome, carrying GFP and human IL-2 genes].
Shmarov MM; Cherenova LV; Shashkova EV; Logunov DIu; Verkhovskaia LV; Kapitonov AV; Neugodova GL; Doronin KK; Naroditskiĭ BS
Mol Gen Mikrobiol Virusol; 2002; (2):30-5. PubMed ID: 12180023
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
Mueller K; Schweier O; Pircher H
Eur J Immunol; 2008 Oct; 38(10):2874-85. PubMed ID: 18825743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
